ArticleInternational journal of clinical oncology2022

Platinum rechallenge treatment using gemcitabine plus carboplatin with or without bevacizumab for platinum-resistant ovarian cancer.

Hiroki Nasu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.